{
  "pmcid": "11075399",
  "sha256": "26c36cb300e3a043171a1df3e79d273c75da75eeab20dcb249bdfa9b73d3af09",
  "timestamp_utc": "2025-11-09T22:00:00.386296+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 18.32880434782609,
    "reading_ease": -5.62157608695648,
    "word_count": 207
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of an Implantable Arterial Access System for Chemotherapy and Peripheral Vascular Disease"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included histologically proven colorectal adenocarcinoma with inoperable hepatic metastases and critical limb ischemia with no option but amputation."
      },
      "Intervention": {
        "score": 2,
        "evidence": "This study evaluated an implantable arterial access system for targeted chemotherapy delivery and isolated arterial-to-arterial extracorporeal perfusion in end-stage peripheral vascular disease."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome for chemotherapy was partial response or stable disease over 11.2 months. For peripheral vascular disease, the primary outcome was avoidance of major amputation over 22 months."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "This single-arm pilot study included 10 patients with secondary colorectal cancer and 20 patients with critical limb ischemia."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "In the chemotherapy group, six out of ten patients achieved partial response or stable disease."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "In the chemotherapy group, six out of ten patients achieved partial response or stable disease. In the peripheral vascular disease group, 40% avoided amputation, and 20% had a delay of 4 months."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included a 4% infection rate and one minor thromboembolic event."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial was registered (ACTRN12611001273976)"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}